|Titre :||Transferring patients from methadone to buprenorphine: The feasibility and evaluation of practice guidelines (2018)|
|Auteurs :||N. LINTZERIS ; L. A. MONDS ; C. RIVAS ; S. LEUNG ; A. DUNLOP ; D. NEWCOMBE ; C. WALTERS ; S. GALEA ; N. WHITE ; M. MONTEBELLO ; A. DEMIRKOL ; N. SWANSON ; R. ALI|
|Type de document :||Article : Périodique|
|Dans :||Journal of Addiction Medicine (Vol.12, n°3, May-June 2018)|
|Article en page(s) :||234-240|
|Discipline :||TRA (Traitement et prise en charge / Treatment and care)|
Thésaurus TOXIBASETRAITEMENT DE MAINTENANCE ; METHADONE ; BUPRENORPHINE ; RECOMMANDATION ; EVALUATION ; ETUDE PROSPECTIVE ; OPIOIDES ; SATISFACTION
INTRODUCTION AND AIMS: Transfer from methadone to buprenorphine is problematic for many opioid-dependent patients, with limited documented evidence or practical clinical guidance, particularly for the range of methadone doses routinely prescribed for most patients (>50 mg). This study aimed to implement and evaluate recent national Australian guidelines for transferring patients from methadone to buprenorphine.
DESIGN AND METHODS: A multisite prospective cohort study. Participants were patients who transferred from methadone to buprenorphine-naloxone at 1 of 4 specialist addiction centers in Australia and New Zealand. Clinicians were trained in the guidelines, and medical records were reviewed to examine process (eg, transfer setting, doses, and guideline adherence) and safety (precipitated withdrawal) measures. Participants completed research interviews before and after transfer-assessing changes in substance use, health outcomes, and side effects.
RESULTS: In all, 33 participants underwent transfer, 9 from low methadone doses (50 mg). The majority of high-dose transfers occurred in inpatient settings. There was reasonable guideline adherence, and no complications identified in the low and medium-dose transfers. Three high-dose transfers (20%) experienced precipitated withdrawal, and 7/33 participants (21%) returned to methadone within 1 week of attempted transfer.
DISCUSSIONS AND CONCLUSIONS: Transfer is feasible in outpatient settings for those transferring from methadone doses below 50 mg; however, inpatient settings and specialist supervision is recommended for higher-dose transfers. The Australian clinical guidelines appear safe and feasible, although further research is required to optimize high-dose transfer procedures.
|Domaine :||Autres substances / Other substances ; Drogues illicites / Illicit drugs|
|Affiliation :||SESLHD Drug and Alcohol Services, Surry Hills, NSW, Australia|